相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro
Lara Milian et al.
PLOS ONE (2020)
Anti-tumour actions of cannabinoids
Burkhard Hinz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Metabolic Infrastructure of Pregnant Women With Trisomy 21 Fetuses; Metabolomic Analysis
Emirhan Nemutlu et al.
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE (2019)
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefania Moreno et al.
FRONTIERS IN PHARMACOLOGY (2019)
The oncogenic role of CB2 in the progression of non-small-cell lung cancer
Shaohua Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia
Miguel Olivas-Aguirre et al.
CELL DEATH & DISEASE (2019)
Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients
Gui-Feng Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway
Ryan Green et al.
SCIENTIFIC REPORTS (2019)
PCL and PCL-based materials in biomedical applications
Elbay Malikmammadov et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2018)
Dual Effect of Glucocorticoid-Induced Tumor Necrosis Factor-Related Receptor Ligand Carrying Mesenchymal Stromal Cells on Small Cell Lung Cancer: A Preliminary in vitro Study
Cagla Zubeyde Kopru et al.
CYTOTHERAPY (2018)
The current state and future perspectives of cannabinoids in cancer biology
Pawel Sledzinski et al.
CANCER MEDICINE (2018)
Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment
J. Remon et al.
FRONTIERS IN ONCOLOGY (2018)
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids
Sayeda Yasmin-Karim et al.
FRONTIERS IN ONCOLOGY (2018)
Metabolomic profiling of human lung tumor tissues - nucleotide metabolism as a candidate for therapeutic interventions and biomarkers
Paula Moreno et al.
MOLECULAR ONCOLOGY (2018)
Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
S. -H. Lee et al.
ANNALS OF ONCOLOGY (2017)
A Review of the Therapeutic Antitumor Potential of Cannabinoids
Visnja Bogdanovic et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2017)
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement
Sun Min Lim et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days
Esther Berrocoso et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
iCELLigence real-time cell analysis system for examining the cytotoxicity of drugs to cancer cell lines (Review)
Leyla Turker Sener et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment
Cem Varan et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2017)
Endocannabinoids modulate apoptosis in endometriosis and adenomyosis
Elif Bilgic et al.
ACTA HISTOCHEMICA (2017)
A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer
Chih-Yang Huang et al.
BIOMEDICINE-TAIWAN (2017)
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies
Kerstin Iffland et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility
M. Duran-Lobato et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2016)
Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor
Javier Romero-Parra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Encapsulation of cannabinoid drugs in nanostructured lipid carriers
Elisabetta Esposito et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I Study
Pasi A. Janne et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
Leonor Puchades-Carrasco et al.
ONCOTARGET (2016)
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Daniel A. Ladin et al.
FRONTIERS IN PHARMACOLOGY (2016)
Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
Caroline Turcotte et al.
FRONTIERS IN PHARMACOLOGY (2016)
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
Agnieszka Gegotek et al.
REDOX BIOLOGY (2016)
Cannabis in Cancer Care
D. I. Abrams et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
In vitro and in vivo evaluation of Δ9-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy
L. Martin-Banderas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Proapoptotic effect of endocannabinoids in prostate cancer cells
O. Orellana-Serradell et al.
ONCOLOGY REPORTS (2015)
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
Maria Haustein et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells
Robert Ramer et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations
Wenhua Liang et al.
PLOS ONE (2014)
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
Janani Ravi et al.
ONCOTARGET (2014)
Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study
Valeria Feinshtein et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation
B. M. Fonseca et al.
APOPTOSIS (2013)
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists
Jessica Brandi et al.
ELECTROPHORESIS (2013)
Preparation and characterization of Δ9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines
Dolores Hernan Perez de la Ossa et al.
JOURNAL OF DRUG TARGETING (2013)
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Robert Ramer et al.
MOLECULAR CANCER THERAPEUTICS (2013)
The endocannabinoid signaling system in cancer
Simona Pisanti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
I. Dando et al.
CELL DEATH & DISEASE (2013)
Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer
Liqin Jiang et al.
NANOSCALE RESEARCH LETTERS (2013)
Cannabinoids inhibit epidermal growth factor receptor transactivation in lung cancer cells
Terry W. Moody et al.
CANCER RESEARCH (2012)
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Wen Cai Zhang et al.
CELL (2012)
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
Robert Ramer et al.
FASEB JOURNAL (2012)
Cannabinoid-associated cell death mechanisms in tumor models (Review)
Giuseppe Calvaruso et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy
D. Hernan Perez de la Ossa et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Development and Validation of an RP-HPLC Method for CB13 Evaluation in Several PLGA Nanoparticle Systems
J. Alvarez-Fuentes et al.
SCIENTIFIC WORLD JOURNAL (2012)
EMT is the dominant program in human colon cancer
Andre Loboda et al.
BMC MEDICAL GENOMICS (2011)
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
Anju Preet et al.
CANCER PREVENTION RESEARCH (2011)
Update on the endocannabinoid system as an anticancer target
Anna Maria Malfitano et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Anandamide-loaded nanoparticles: Preparation and characterization
M. R. Aberturas et al.
JOURNAL OF MICROENCAPSULATION (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Type I Cannabinoid Receptor Trafficking: All Roads Lead to Lysosome
Raphael Rozenfeld
TRAFFIC (2011)
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
M. Donadelli et al.
CELL DEATH & DISEASE (2011)
Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists
R. G. Pertwee
CURRENT MEDICINAL CHEMISTRY (2010)
Effect of a Synthetic Cannabinoid Agonist on the Proliferation and Invasion of Gastric Cancer Cells
Xiang-Shu Xian et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Maria M. Caffarel et al.
MOLECULAR CANCER (2010)
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: Involvement of the transcription factor PPARγ
Michela Giuliano et al.
BIOCHIMIE (2009)
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2
N. Olea-Herrero et al.
BRITISH JOURNAL OF CANCER (2009)
Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242
I. Mancini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors
Dai-Fei Wu et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo
A. Preet et al.
ONCOGENE (2008)
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells
E. Gkoumassi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Constitutive endocytic cycle of the CB1 cannabinoid receptor
C Leterrier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
